CH275315A - Process for the preparation of pregnane-3,11,20-trione. - Google Patents

Process for the preparation of pregnane-3,11,20-trione.

Info

Publication number
CH275315A
CH275315A CH275315DA CH275315A CH 275315 A CH275315 A CH 275315A CH 275315D A CH275315D A CH 275315DA CH 275315 A CH275315 A CH 275315A
Authority
CH
Switzerland
Prior art keywords
trione
treatment
acetic acid
glacial acetic
pregnane
Prior art date
Application number
Other languages
German (de)
Inventor
Nv Organon
Original Assignee
Nv Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nv Organon filed Critical Nv Organon
Publication of CH275315A publication Critical patent/CH275315A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Description

  

  Verfahren zur Herstellung von     Pregnan-3,11,20-trion.       Gegenstand der     Erfindung    ist ein Ver  fahren zur Herstellung von     Pregnan-3,11,20-          trion,    einem     wiehtigen        Zwisehenprodukt    zur       Svntllece    von Hormonen der     --'"-ebenniei#en-          rinde.     



  Das erfindungsgemässe Verfahren ist     da-          dureh        gekennzeiehnet,    dass A     ll,la-pregnen-          ,:,20-dion        dureh        Behandlung    mit     Bromaeet-          a@ni(#    in     Gegenwart    von Wasser in das     Halo-          genliydrin    der Formel:

    
EMI0001.0022     
    übergeführt wird, das genannte     Zwi.schien-          produkt    sodann durch Behandlung mit einem  oxydierenden Mittel in     12-Brom-pregnan-          3,11,20-trion    umgewandelt und aus letzterem  durch Behandlung mit. reduzierenden Mitteln  (las     Halogen    entfernt wird. Das Endprodukt  kristallisiert in zu     Drusell    vereinigten Nadeln  vom     Smp.    151 bis<B>1560</B> C. Die     spez.    Drehung  beträgt (a) D = + 119,50   20 (e = 1,03  in Aceton).  



  Das     Ausgangsmaterial    wird beispielsweise  aus     Pregnan-12-o1-2,20-.dion    vom     Smp.    182 bis       18-1o    C     durell        Benzoylierung    und     ansehlie-          ssende    Abspaltung von     Benzoesäure    gewon  nen.    Als oxydierendes Mittel wird vorzugsweise       Chromtrioxyd    in Eisessig verwendet.

   Das er  findungsgemässe Verfahren wird im folgen  clen durch eine bevorzugte Ausführungsform  erläutert  <I>Beispiele:</I>       a)    650 mg     ,A        11,1'-Pregnen-3,20-,dion    vom       Smp.    131 bis<B>1330</B> C wurden in 100     cm3    Ace  ton aufgelöst, die Lösung mit 0,6 g     N-Brom-          aeetamid    und 10     em3        Wasser    versetzt und das  Ganze bei 20  C     stehengelassen.    Die anfangs  farblose Lösung färbte sieh nach einigen  Stunden gelb, war aber     naeh    12 Stunden wie  der farblos.

   Nach Zusatz von etwas Wasser  wurde das     Aeeton    im Vakuum entfernt, wo  bei die Hauptmenge des     organisehen    Mate  rials sieh als harzige Masse an der Kolben  wand ansetzte. Das Wasser wurde abgegossen  und der     Rüekstand    zweimal mit wenig fri  schem Wasser ausgewaschen.

   Die vereinigten       -\\'asehwässer    wurden     zweimal    mit viel Äther       #        itus   <B><U>-</U></B>     e        schüttelt        und        das        Harz        für        sich        mit     wenig     absolutem    Äther versetzt, wobei reich  liehe Mengen von Kristallen ungelöst blieben.  Diese wurden     abgenutseht,    mit Äther gut aus  gewaschen und dann im Vakuum getrocknet.

    Das     H.alogenhydrin    wurde in Form von     meist     dreieckigen, farblosen     Blättehen    erhalten mit  einem Schmelzpunkt von ungefähr 238 bis  2450 C     (unter    Zersetzung).  



  b)     .120    mg des kristallinen     Halogenhydrins     wurden in 25     ems        mögliehst    alkoholfreiem  Chloroform suspendiert, mit 10     cm3    reinstem  Eisessig und hierauf mit.

   5     cln3    einer 2     o/oigen              Chromtrioxyd-Eisessig-Lösung    (= 100 mg       Cr03)    versetzt und 2 Stunden bei     Zimmex't.em-          peratur        stehengelassen.    Das Chloroform  wurde sodann im Vakuum bei 200 C Bad  temperatur möglichst weitgehend entfernt,  der Rückstand mit 10     em3    Eisessig und 2,5     em3     2     o/oxger        Chromsäurelösung    versetzt und wie  der bei     Zimmertemperatur    stehengelassen.  



  Insofern nach 3 Stunden keine freie  Chromsäure mehr nachweisbar ist., wird er  neut 2,5     cm3    2     o/oige        Chromsäurelösung        7uge-          setzt        und    dies so oft wiederholt, bis nach  3stündigem Stehen sich noch deutlich Chrom  säure nachweisen liess. Insgesamt sind hierzu  etwa 21     em@    der 2     o/oigen        Chromsäurelösung     (= 420 mg     Cr0    3) nötig.  



  Die Aufarbeitung nach einer üblichen  Methode lieferte das     12-Brom-pregnan-3,11,20-          trion    in farblosen Blättchen vom     Smp.    176  bis     184     C.  



  e) 240 mg des erhaltenen     Ketobromids          wurden    in 10     enx3    Eisessig aufgelöst, mit       -100    mg Zinkstaub versetzt und die     -liseliung          unter    anhaltendem Umschwenken 15 Minuten  auf 800 C erwärmt. Durch Filtrieren, Ein  engen des Filtrates im Vakuum, Versetzen mit  Wasser und     Ausäthern    wurde :das     Pregnan-          3,11,20-trion    in Form von zu     Drusen    ver  einigten Nadeln vom     Smp.    154 bis 1560 C  erhalten.  



  Die     illutterlaugen    der Reaktionsstufe     a.)     wurden wie unter b) beschrieben     oxydiert     und das     Oxydationsprodukt        zusammen    mit  den Mutterlaugen der Reaktionsstufe b)     ent-          bromt.        Hierdurch    wurde neben einer     7usätz-          lichen    Menge von     Pregnan-3,11,20-trion    auch  etwas     .19,11-Pregnen-3,12,20-trion    vom     Smp.          184    bis 1860 C gewonnen.



  Process for the preparation of pregnane-3,11,20-trione. The invention relates to a process for the production of pregnan-3,11,20-trione, a weighty intermediate product for the use of hormones of the - '"- ebenniei # en rind.



  The method according to the invention is characterized in that A ll, la-pregnen-,:, 20-dione by treatment with Bromaeet- a @ ni (# in the presence of water into the halogen liydrin of the formula:

    
EMI0001.0022
    is converted, the intermediate product mentioned is then converted into 12-bromo-pregnan-3,11,20-trione by treatment with an oxidizing agent and from the latter by treatment with. reducing agents (the halogen is removed. The end product crystallizes in needles combined to form Drusell with a melting point of 151 to 1560 C. The specific rotation is (a) D = + 119.50 20 (e = 1 , 03 in acetone).



  The starting material is obtained, for example, from pregnane-12-01-2,20-.dione with a melting point of 182 to 18-10 C by benzoylation and the subsequent elimination of benzoic acid. Chromium trioxide in glacial acetic acid is preferably used as the oxidizing agent.

   The method according to the invention is explained in the following by a preferred embodiment <I> Examples: </I> a) 650 mg, A 11,1'-pregnene-3,20-, dione of melting point 131 to 1330 </B> C were dissolved in 100 cm3 of acetone, 0.6 g of N-bromoetamide and 10 em3 of water were added to the solution, and the whole thing was left to stand at 20 ° C. The initially colorless solution turned yellow after a few hours, but was colorless like that after 12 hours.

   After adding a little water, the acetone was removed in vacuo, where the main amount of the organic material was attached to the wall of the flask as a resinous mass. The water was poured off and the residue was washed out twice with a little fresh water.

   The combined - \\ 'aseh waters were shaken twice with a lot of ether # itus <B><U>-</U> </B> e and the resin was mixed with a little absolute ether, with abundant amounts of crystals remaining undissolved . These were removed, washed off well with ether and then dried in vacuo.

    The halohydrin was obtained in the form of mostly triangular, colorless leaves with a melting point of approximately 238 to 2450 C (with decomposition).



  b) .120 mg of the crystalline halohydrin were suspended in 25 ems as possible alcohol-free chloroform, with 10 cm3 of the purest glacial acetic acid and then with.

   5 cln3 of a 2% chromium trioxide glacial acetic acid solution (= 100 mg Cr03) were added and the mixture was left to stand for 2 hours at room temperature. The chloroform was then largely removed in vacuo at a bath temperature of 200 ° C., the residue was treated with 10 cubic meters of glacial acetic acid and 2.5 cubic centimeters of chromic acid solution and left to stand again at room temperature.



  If free chromic acid is no longer detectable after 3 hours, another 2.5 cm3 2% chromic acid solution is added and this is repeated until after 3 hours of standing chromic acid can still be clearly detected. A total of about 21 em @ of the 2% chromic acid solution (= 420 mg Cr0 3) are necessary for this.



  Working up by a customary method yielded the 12-bromo-pregnane-3,11,20-trione in colorless leaflets with a melting point of 176 to 184 C.



  e) 240 mg of the ketobromide obtained were dissolved in 10 enx3 glacial acetic acid, -100 mg zinc dust was added and the solution was heated to 800 ° C. for 15 minutes while swirling continuously. By filtering, narrowing the filtrate in vacuo, adding water and extracting ether, the following was obtained: the pregnan-3,11,20-trione in the form of needles with a melting point of 154 to 1560 ° C. which were combined to form drusen.



  The mother liquors from reaction stage a.) Were oxidized as described under b) and the oxidation product was defbrominated together with the mother liquors from reaction stage b). As a result, in addition to an additional amount of pregnane-3,11,20-trione, some 19,11-pregnene-3,12,20-trione with a melting point of 184 to 1860 ° C. was obtained.

 

Claims (1)

<B>PATENTANSPRUCH:</B> Verfahren zur Herstellung von Pregnan- 3,11,20-trion, dadurch gekennzeichnet, dass J ii,xz_pre;-nen-3,20-clion durch Behandlung mit. Bromacetamid in Gegenwart. von Wasser in das Halogenhydrin der Formel: <B> PATENT CLAIM: </B> Process for the production of pregnan-3,11,20-trione, characterized in that J ii, xz_pre; -nen-3,20-clion by treatment with. Bromoacetamide in the presence. of water into the halohydrin of the formula: EMI0002.0058 übergeführt wird, das genannte Zwiselienpro- dukt sodann durch Behandlung mit einem cxydierenden Mittel in 12-Bx.oxü-pregnan- 3,11,20-trion übergeführt und aus letzterem durch Behandlung mit reduzierenden -Mitteln das Halogen entfernt wird. Das Endprodukt. kristallisiert in zu Drusen vereinigten Nadeln vom Smp. 15-1 bis<B>1560</B> C. EMI0002.0058 The said Zwiselienprodu- t is then converted into 12-Bx.oxü-pregnan- 3,11,20-trione by treatment with an oxidizing agent and the halogen is removed from the latter by treatment with reducing agents. The end product. crystallizes in needles with a melting point of 15-1 to <B> 1560 </B> C. Die spez. Drehung beträgt (a) D = -i- <B>119,50</B> - 20 (e = 1,03 in Aceton). UNTERANSPRÜCHE 1. Verfahren naeh Patentansprueli, da durch gekennzeichnet., class die Oxydation des Halogenhydrins durch Behandlung mit Chromtrioxy d in Eisessig erfolgt. The spec. Rotation is (a) D = -i- 119.50 - 20 (e = 1.03 in acetone). SUBClaims 1. Method according to patent claims, as characterized by., The oxidation of the halohydrin takes place by treatment with chromium trioxide in glacial acetic acid. 2. Verfahren naeh Patentansprueh, da durch gekennzeichnet, dass die Entbromung des 12-Broin-pre@nan-3,11,20-trion durch Be- liandlung mit Zinkstaub in Eisessig erfolgt. 2. Process according to patent claim, characterized in that the debromination of the 12-broin-pre @ nan-3,11,20-trione is carried out by treatment with zinc dust in glacial acetic acid.
CH275315D 1942-10-08 1942-10-08 Process for the preparation of pregnane-3,11,20-trione. CH275315A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH275315T 1942-10-08
CH251117T 1942-10-08

Publications (1)

Publication Number Publication Date
CH275315A true CH275315A (en) 1951-05-15

Family

ID=25729507

Family Applications (1)

Application Number Title Priority Date Filing Date
CH275315D CH275315A (en) 1942-10-08 1942-10-08 Process for the preparation of pregnane-3,11,20-trione.

Country Status (1)

Country Link
CH (1) CH275315A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142690A (en) * 1956-01-25 1964-07-28 Merck & Co Inc 12alpha-halo-pregnenes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142690A (en) * 1956-01-25 1964-07-28 Merck & Co Inc 12alpha-halo-pregnenes

Similar Documents

Publication Publication Date Title
CH275315A (en) Process for the preparation of pregnane-3,11,20-trione.
AT160853B (en) Process for the preparation of unsaturated and saturated 21-substituted derivatives of pregnanol- (3) -one- (20).
DE873699C (en) Process for the preparation of oxygen-rich derivatives of unsaturated compounds of the androstane and pregnane series
DE2658840A1 (en) PHARMACEUTICAL COMPOSITION
DE699248C (en) Dihalo-3-ketones of the cyclopentanopolyhydrophenanthrene series
CH284986A (en) Process for the preparation of a derivative of pregnane-3,11,20-trione.
AT213898B (en) Process for the preparation of the new 3-p-amino-benzenesulfonamido-6-oxy-pyridazine and its salts
AT287930B (en) Process for the manufacture of new steroids
CH229982A (en) Process for the preparation of 5,7-dichloro-8-oxychinaldine.
CH232273A (en) Process for the production of a cyclopentano-dimethyl-polyhydro-phenanthrene-carboxylic acid.
DE739084C (en) Process for the dehalogenation of addition products of halogen on unsaturated derivatives of the Pregnan series or their ketolab particles
AT219038B (en) Process for the preparation of new isoindoline derivatives
DE864256C (en) Process for the preparation of saturated and unsaturated 21-substituted derivatives of pregnan-3-ol-20-one
DE576965C (en) Process for the production of ketocholanic acids
DE896646C (en) Process for the selective oxidation of the 3-oxy group in A17-3, 21-dioxy-11-keto-20-cyanpregnen
CH273600A (en) Process for the preparation of a compound of the cyclopentanopolyhydrophenanthrene series which contains an oxygen-containing group in ring C.
AT254178B (en) Process for the preparation of the new 3-acylaminomethyl-5-acylamino-2,4,6-triiodobenzoic acids, their alkyl esters and salts
DE935969C (en) Process for the production of ª ‡, ª ‰ -unsaturated steroid ketones
AT164549B (en) Process for the production of sterol degradation products
AT225858B (en) Process for the preparation of 3β-acyloxy- and 3β-hydroxy-6-methylpregna-5, 16-dien-20-one
DE859008C (en) Process for the preparation of oxyquinones
AT240540B (en) Process for the preparation of 4-chloro-Δ &lt;4&gt; -3-ketosteroid compounds
AT160572B (en) Process for the preparation of unsaturated oxyketones of the cyclopentanopolydrophenanthrene series or their derivatives.
CH234347A (en) Process for the production of progesterone.
DE1101415B (en) Process for the preparation of 6ª ‡ -Methyl-17ª ‡ -acetoxy-4-pregnen-3, 20-dione